COMPANY
Edison Investment Research

Edison Investment Research
Leading International Investment Research

5.0k
Insights
1.6m
Views
7
Followers
Equities
Refresh
bullishOSE Immuno
29 Feb 2024 01:10Issuer-paid

OSE Immunotherapeutics - Confidence boost with AbbVie partnership

OSE Immunotherapeutics has announced a global licence and collaboration agreement with AbbVie to develop OSE-230, a novel monoclonal antibody, for...

Share
29 Feb 2024 01:10Issuer-paid

Egdon Resources - Termination of coverage

Edison Investment Research is terminating coverage on Egdon Resources (EDR). Please note you should no longer rely on any previous research or...

Share
28 Feb 2024 19:10Issuer-paid

Pan American Silver - FY23 results: Follow the cash flow

Pan American Silver (PAAS) has released its FY23 financial results, which are in line with our estimates at the EBITDA level, an encouraging...

Share
bullishOSE Immuno
28 Feb 2024 01:10Issuer-paid

OSE Immunotherapeutics - Encouraging OSE-279 clinical update

At the 2024 ESMO Targeted Anticancer Therapies Congress, OSE Immunotherapeutics (OSE) presented encouraging interim results from the Phase I/II...

Share
27 Feb 2024 19:10Issuer-paid

Immix Biopharma - 2023 recap with a preview of active year ahead

IMMX has shared a 12-month recap, capturing key clinical and regulatory events from 2023, setting the stage for an active 2024. Its lead CAR-T...

Share
x